|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Valves in the Heart of the Big Apple: Evalutation and Management of Valvular Heart Diseases 2001 | ||||||||||||||||
| February 15, 2001 | ||||||||||||||||
|
Weill Medical College of Cornell University, New York CIty May 10 - 12, 2001 Thursday, May 10, 2001 12:00-1:30 Registration 1:30 – 1:40 Daniel J. Williford, M.D., Ph.D. President, New York Cardiological Society of the American College of Cardiology, New York State Chapter and President-elect, American College of Cardiology, New York State Chapter 1:40 – 2:00 Introduction and Symposium Goals Jeffrey S. Borer, MD; O. Wayne Isom, M.D. 2:00 – 3:20 OVERVIEW Chairman: O. Wayne Isom, M.D. 2:00 – 2:20 THE HONORS LECTURE Historical Perspectives on Valve Disease Management David C. Sabiston, Jr. 2:20 – 2:40 The Epidemiology of Valvular Heart Diseases: An Emerging Public Health Problem Phyllis Supino, Ed.D. 2:40 – 3:00 The cellular and molecular basis of heart failure in valvular diseases: basis for future therapy Jeffrey S. Borer, M.D. 3:00 – 3:20 Diastolic Function and the Pathophysiology of Heart Failure in Valvular Diseases Martin St. John Sutton, M.D. 3:20 – 3:40 Coffee Break 3:40 – 5:20 AORTIC STENOSIS Chairman: Blase Carabello, M.D. 3:40 – 3:55 Cholesterol and progression of aortic stenosis: is there a mandate for lipid modification in patients with non-critical AS? Allan Schwartz, M.D. 3:55 – 4:20 Selection of patients for operation: the asymptomatic patient and the patient with poor LV function Blase Carabello, M.D. 4:20 – 4:35 Radionuclide-based assessment: biological information and impact on need for pre-operative coronary arteriography Steven Horowitz, M.D. 4:35 - 4:55 Congenital aortic stenosis – is repair an option? Current techniques, comparative statistics John Lamberti, M.D. 4:55 – 5:20 Factors determining selection of valve prosthesis – tissue or mechanical: current status Timothy Gardner, M.D 6:00 – 7:00 Cocktail Reception Friday, May 11, 2001 7:00 – 8:00 Continental Breakfast 8:00 – 10:30 AORTIC REGURGITATION Chairman: Robert O. Bonow, M.D. 8:00 – 8:20 Etiology and the role of vascular pathology: is the face of the disease changing? Valentin Fuster, M.D., Ph.D. 8:20 – 8:35 Is there a role for pharmacologic prophylaxis? Robert O. Bonow, M.D. 8:35 – 9:05 Selection of asymptomatic patients for operation Jeffrey S. Borer, M.D. 9:05 – 9:20 Surgical approaches when AR is associated with aortic root disease Leonard Girardi, M.D 9:40 – 10:00 Is the aortic valve autograft a viable surgical option? Current techniques, comparative statistics Paul Stelzer, M.D 10:00 – 10:30 Panel Discussion: Illustrative cases Chairman: Edmund Herrold, M.D., Ph.D Panelists: Drs. Bonow, Borer, Stelzer, Girardi 10:30 – 10:50 Coffee Break 10:50 – 11:50 INFECTIVE ENDOCARDITIS Chairman: Jeffrey Gold, M.D. 10:50 – 11:10 Infective agents, natural history and the changing face of prophylaxis Barry Hartman, M.D. 11:10 – 11:30 Timing of surgery, medical/surgical therapy comparison Jeffrey Gold, M.D. 11:30 – 11:50 Echocardiographic assessment of the vegetation: are there characteristics that mandate prophylactic surgery? Marvin Berger, M.D. 12:15 – 1:45 Luncheon Speaker to be announced 2:00 – 5:30 MITRAL REGURGITATION Chairman: Mark Starling, M.D. 2:00 – 2:20 Natural history in operated and unoperated patients Clare Hochreiter, M.D. 2:20 – 2:40 Prognosis and complications of mitral valve prolapse Robert M. Jeresaty, M.D. 2:40 – 3:00 The emerging cell biology of MR: implications for future therapy Mark Starling, M.D. 3:00 – 3:25 Predictors of outcome: when to operate Maurice Enrique Sarano, M.D. 3:25 – 3:45 The importance of the right ventricle in decisions to operate Jeffrey S. Borer, M.D. 3:45 – 4:15 Debate: When mitral regurgitation is caused by ischemia, combined coronary bypass and mitral valve surgery should be performed before mitral regurgitation is severe. Pro: Lawrence Cohn, M.D. Con: John Elefteriadis, M.D. 4:15 – 4:35 Repair of congenital mitral valve anomalies: selection of patients, current techniques and statistics Jan Quagebeur, M.D 4:35 – 4:55 When should transplantation replace mitral valve surgery for the patient with mitral regurgitation? Niloo Edwards, M.D. 4:55 – 5:30 Illustrative and Controversial Cases: Panel Discussion Chairperson: Claire Hochreiter, M.D. Panelists: Drs. Starling, Sarano, Cohn, Borer, Isom, Elefteriades, Edwards Saturday, May 12, 2001 7:00 – 8:00 Continental Breakfast 8:00 – 8:20 THE HOWARD GILMAN FOUNDATION LECTURE Aortic Valve Disease: Current Perspective William C. Roberts, M.D. 8:20 – 9:40 MITRAL STENOSIS Chairman: William C. Roberts, M.D. 8:20 – 8:40 Catheter-based therapy: Does it really last as long and do as well as surgery? Igor Palacios, M.D 8:40 – 9:00 Atrial fibrillation: implications for management decisions and pharmacologic therapy John C. Somberg, M.D. 9:00 – 9:20 Surgical options: commissurotomy, heterografting, homografting, artificial prosthesis implantation: criteria for choice O. Wayne Isom, M.D. 9:20 – 9:40 Rheumatic fever and valvulitis: is it still with us? New approaches to diagnosis Jagat Narula, M.D., Ph.D. 9:40 – 10:00 Coffee Break 10:00 – 11:20 NEW APPROACHES TO SURGICAL MANAGEMENT Chairman: Karl Krieger, M.D. 10:00 – 10:20 Emerging role of complementary medicine in valvular surgery Mehmet Oz, M.D. 10:20 – 10:40 Strategies for blood conservation in valvular surgery Karl Krieger, M.D. 10:40 – 11:20 “Minimally invasive” valve surgery: is it truly an advantage? 10:40 – 11:00 Aortic valve replacement Craig Smith, M.D 11:00 – 11:20 Mitral valve replacement and repair Aubrey Galloway, M.D 11:20 – 11:30 Concluding remarks Drs. Isom and Borer 11:30 – 12:00 Participants complete and submit course evaluation 12:00 ADJOURN |
||||||||||||||||
| Organized by: | The Howard Gilman Institute for Valvular Heart Diseases | |||||||||||||||
| Invited Speakers: | Course Directors Jeffrey S. Borer, M.D.; Gladys & Roland Harriman Professor of Cardiovascular Medicine, Weill Medical College of Cornell University; Professor of Cardiovascular Medicine in Radiology and in Cardiothoracic Surgery, Weill Medical College; Co-Director, The Howard Gilman Institute for Valvular Heart Diseases, Weill Medical College; Chief, Division of Cardiovascular Pathophysiology, New York - Presbyterian Hospital New York Weill Cornell Center. O. Wayne Isom, M.D.; Professor and Chairman, Department of Cardiothoracic Surgery, Weill Medical College of Cornell University; Co-Director, The Howard Gilman Institute for Valvular Heart Diseases, Weill Medical College; Chairman, Department of Cardiothoracic Surgery, New York - Presbyterian Hospital New York Weill Cornell Center. Faculty: Marvin Berger, M.D.; Professor of Clinical Medicine, Albert Einstein College of Medicine; Director, Echocardiography Laboratory, Beth Israel Medical Center, New York City Robert O. Bonow, M.D.; Goldberg Distinguished Professor of Medicine and Chief, Division of Cardiology, Northwestern University Medical School, Chicago, IL Blase Carabello, M.D.; The W.A. “Tex” and Deborah Moncrief Jr. Professor of Medicine, Baylor College of Medicine; Vice Chairman, Department of Medicine, Baylor College of Medicine; Medical Care Line Executive, Houston VA Medical Center, Houston, TX Lawrence Cohn, M.D.; Professor of Surgery, Harvard Medical School; Chief, Division of Cardiac Surgery, Brigham and Women’s Hospital, Boston, MA Niloo Edwards, M.D.; Assistant Professor of Surgery, College of Physicians and Surgeons, Columbia University, New York City John Elefteriadis, M.D.; Professor and Chief, Cardiothoracic Surgery, Yale University School of Medicine, New Haven, CT Valentin Fuster, M.D., Ph.D.; Richard Gorlin M.D./Heart Research Foundation Professor of Cardiology; Director, The Zena and Michael A. Weiner Cardiovascular Institute, Mount Sinai School of Medicine, New York City Aubrey Galloway, M.D.; Professor of Surgery, Cardiothoracic Surgery, New York University School of Medicine, New York City Timothy Gardner, M.D.; William M. Measey Professor of Surgery, University of Pennsylvania School of Medicine; Chief, Division of Cardiothoracic Surgery, University of Pennsylvania School of Medicine and Hospital of the University of Pennsylvania, Philadelphia, PA Leonard Girardi, M.D.; Assistant Professor of Cardiothoracic Surgery, Weill Medical College of Cornell University, New York City Jeffrey P. Gold, M.D.; Professor and Chairman, The University Department of Cardiothoracic Surgery, Albert Einstein College of Medicine; Cardiothoracic Surgeon-in-Chief, The Montefiore – Einstein Heart Center, New York City Barry Hartman, M.D.; Clinical Professor of Medicine, Weill Medical College of Cornell University, New York City Edmund Herrold, M.D., Ph.D.; Associate Professor of Medicine and of Cardiothoracic Surgery, Weill Medical College of Cornell University; Director, Section of Biomechanics, Division of Cardiovascular Pathophysiology, New York – Presbyterian Hospital New York Weill Cornell Center, New York City Clare Hochreiter, M.D.; Associate Professor of Medicine and of Cardiothoracic Surgery, Weill Medical College of Cornell University; Director, Section of Clinical Trials and Clinical Research, Division of Cardiovascular Pathophysiology, New York – Presbyterian Hospital New York Weill Cornell Center, New York City Steven Horowitz, M.D.; Professor of Medicine and Nuclear Medicine, Albert Einstein College of Medicine; Chief, Division of Cardiology, Beth Israel Medical Center, New York City Robert M. Jeresaty, M.D.; Professor of Medicine, University of Connecticut School of Medicine, Farmington, CT; Emeritus Chief, Division of Cardiology, St. Francis Hospital and Medical Center, Hartford, CT Karl Krieger, M.D.; Bergerac Professor of Cardiothoracic Surgery, Weill Medical College of Cornell University;Vice Chairman, Department of Cardiothoracic Surgery, New York – Presbyterian Hospital New York Weill Cornell Center, New York City John Lamberti, M.D.; Associate Professor of Cardiothoracic Surgery, Weill Medical College of Cornell University, New York City Jagat Narula, M.D., Ph.D.; Professor of Medicine and Associate Chief, Division of Cardiovascular Disease, MCP Hahnemann University; Director, Centers of Molecular Cardiology and Heart Failure Transplantation and Research, Hahnemann University Hospital, Philadelphia, PA Mehmet Oz, M.D.; Irving Associate Professor of Surgery, College of Physicians and Surgeons, Columbia University, New York City Igor Palacios, M.D.; Associate Professor of Medicine, Harvard Medical School; Director, Cardiac Catheterization Laboratories and Interventional Cardiology, Massachusetts General Hospital, Boston, MA Jan Quagebeur, M.D Professor of Surgery, College of Physicians and Surgeons, Columbia University; Adjunct Professor of Surgery, Weill Medical College of Cornell University, New York City William C. Roberts, M.D.; Dean, A. Webb Roberts Center of Continuing Education, Baylor University Medical Center; Medical Director, Baylor Cardiovascular Institute, Baylor University Medical Center, Dallas, TX; Editor, American Journal of Cardiology David C. Sabiston, Jr.; James B. Duke Professor of Surgery and Chairman Emeritus of Surgery; Duke University School of Medicine, Durham, N.C. Maurice Enrique Sarano, M.D.; Associate Professor of Medicine, Mayo Medical School; Consultant, Thoracic and Cardiovascular Surgery, Mayo Clinic, Rochester, MN Allan Schwartz, M.D.; Harold Ames Hatch Professor of Clinical Medicine, College of Physicians and Surgeons, Columbia University; Chief, Division of Cardiology, New York – Presbyterian Hospital Columbia – Presbyterian Medical Center, New York City Craig Smith, M.D.; Professor of Surgery, College of Physicians and Surgeons, Columbia University; Chief of Cardiac Surgery, New York – Presbyterian Columbia-Presbyterian Medical Center, New York City John C. Somberg, M.D.; Professor and Chief, Division of Clinical Pharmacology, Rush Medical School, Rush – Presbyterian Medical Center, Chicago, IL; Editor-in-Chief, American Journal of Therapeutics Martin St. John Sutton, M.D.; John Bryfogel Professor of Cardiovascular Diseases, University of Pennsylvania School of Medicine; Director, Cardiovascular Imaging Program, Hospital of the University of Pennsylvania, Philadelphia, PA Mark Starling, M.D.; Professor of Internal Medicine and Associate Chief, Division of Cardiology, University of Michigan Medical School; Chief, Cardiology Section, VA Medical Center, Ann Arbor, MI Paul Stelzer, M.D.; Associate Professor of Surgery, Albert Einstein College of Medicine; Beth Israel and St. Luke’s – Roosevelt Hospitals, New York City Phyllis Supino, Ed.D.; Associate Research Professor of Public Health in Medicine and Clinical Associate Professor of Public Health, Weill Medical College of Cornell University; Director, Section of Data Management and Educational Programs, Division of Cardiovascular Pathophysiology, New York – Presbyterian Hospital New York Weill Cornell Center, New York City |
|||||||||||||||
| Deadline for Abstracts: | N/A | |||||||||||||||
| Registration: | Registration VALVES IN THE HEART OF THE BIG APPLE: Evaluation and Management of Valvular Heart Diseases 2001 May 10 - 12, 2001 To register, please complete the registration form below and return it by mail or fax. Registration fee includes tuition, course syllabus, Thursday evening reception, Friday and Saturday continental breakfasts, Friday luncheon and daily refreshment breaks. Mail form to: Valves in the Heart of the Big Apple 254 East 68th Street Suite #4F New York, NY 10021 Or, fax form to 212/452-2027 For more information: call 212/561-1627 or e-mail: msljy@lesliejyerman.com Print or type all information. Duplicate form for multiple registrations. Name______________________________________________ Title________ Institution________________________________________________________ Address_________________________________________________________ City________________________________ State____ Zip Code_________ Telephone __________________________ Fax_________________________ E-mail___________________________________________________________ Fees Early registration (prior to March 23, 2001) – $500 ACC members – $525 Fellows & Residents - $325 (with letter from training director) All others – $595 Payment Total amount due: __________ __ check enclosed (payable to Cornell Heart Valve Disease Conference) __ credit card (American Express, MasterCard and Visa) ____________________________________________________________ card number expiration date (month/year) _________________________________________________________________________ signature date Course Cancellation Policy If you must cancel your registration, a refund of tuition minus a $50 administrative fee will be made if notification is received prior to April 20, 2001. No refunds will be made after April 20, 2001. |
|||||||||||||||
| E-mail: | msljy@lesliejyerman.com | |||||||||||||||
| Posted by: | leslie j. yerman | |||||||||||||||
| Host: | user-2iveb2r.dialup.mindspring.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||